| Nov 11 |
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
|
| Nov 5 |
Organogenesis Holdings And 2 Other US Penny Stocks To Watch
|
| Oct 30 |
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested three years ago
|
| Oct 16 |
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
|
| Oct 15 |
Organogenesis: Lurking Disruption With Recovery To Follow
|
| Oct 1 |
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
|
| Sep 4 |
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
|
| Aug 10 |
Organogenesis Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Jul 20 |
Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?
|
| Jul 15 |
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
|
